Analysis, Digital Health and Drug Development

Drug Discovery and Early Development Outsourcing Services Industry Analysis – M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion – ResearchAndMarkets.com

Digital Health Global

APRIL 5, 2024

Furthermore, the industry witnessed a decline in the average return on investment (ROI) for R&D to as low as 1.2%, and the peak sales per asset valued just above $350 million, indicating a need to build more efficient drug development processes with the implementation of newer technologies.

Drug Development

Drug Development Pharmaceuticals Digital Health Health Technology

Debiopharm and ThinkingNodeLife.ai Forge a Strategic Partnership to Propel Cancer Drug Development with AI Digital Cell Clones

Digital Health Global

JANUARY 10, 2024

Key Highlights of the Partnership: 1) Expanding Indications : The partnership will harness TNL’s AI Digital Cells Lab platform to explore additional indications for one of Debiopharm’s cancer drugs. Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.

Drug Development

Drug Development Pharmaceuticals Digital Health

COVID-19 has accelerated adoption of non-contact patient monitoring technology, says Frost & Sullivan analysis

Healthcare IT News - Telehealth

MAY 29, 2020

Contactless monitoring systems and smartphone health applications are playing a vital role in the war against COVID-19, a report has found. Telemedicine has experienced a huge surge in adoption over the past few months, during the coronavirus pandemic, according to Aline Noizet , founder of Digital Health Connector.

Mental health

Mental health Drug Development Pharmaceuticals Telehealth

The next revolution in the pharmaceutical industry: the transformative potential of AI

Digital Health Global

SEPTEMBER 19, 2023

Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care. AI algorithms come into play in this complexity by orchestrating the analysis of intricate molecular dynamics.

Pharmaceuticals

Pharmaceuticals Drug Development Digital Health

Digital Healthcare Transformation: Improving Patient Experience and Outcomes

Digital Health Global

MAY 10, 2023

Enhancing outcomes for patients with the implementation of digital technologies, such as artificial intelligence (AI) and big data analysis, empowers healthcare professionals to make better-informed decisions. Artificial Intelligence is utilized in various areas of healthcare, ranging from drug development to medical image analysis.

Patient Experience

Patient Experience Mobile Health Telemedicine Drug Development

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

Digital Health Global

JUNE 13, 2023

The Beacon Platform unlocks longitudinal, at-home EEG technology, applies machine-learning algorithms to maximize insights into brain activity, and empowers sponsors with comprehensive data analysis and data visualization capabilities.

Drug Development

Drug Development eMed BioTech Digital Health

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

Lloyd Price

APRIL 22, 2024

Here are some of the ways that machine learning and computational algorithms are being used to aid diagnostics: Image analysis: Machine learning algorithms can be trained to identify abnormalities in medical images, such as X-rays, mammograms, and CT scans. Visit www.nelsonadvisors.co.uk Subscribe Today! Email lloyd@nelsonadvisors.co.uk

healthcare technology

healthcare technology Leadership Drug Development Digital Health

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Lloyd Price

NOVEMBER 21, 2023

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!

Drug Development

Drug Development Health science healthcare technology Leadership

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

FEBRUARY 18, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!

Pharmaceuticals

Pharmaceuticals healthcare technology Digital Health Leadership

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Lloyd Price

FEBRUARY 18, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!

Pharmaceuticals

Pharmaceuticals healthcare technology Leadership Drug Development

Bonus Features – August 7, 2022 – Patients like digital health but have security concerns, healthcare leaders optimistic “seamless” care is coming, and more

Healthcare IT Today

AUGUST 7, 2022

Data platform H1 is teaming with Lokavant , a clinical trial analytics vendor, to help clinical trial teams determine the best sites for trials in an effort to accelerate drug development. Physical therapy smartphone app OneStep announced fall risk detection capabilities based on gait analysis.

eCare

eCare Digital Health Drug Development Healthcare IT

Cornerstone AI Raises $5 Million Seed to Solve Healthcare’s Data Problem

Healthcare IT Today

JULY 25, 2022

Cornerstone is developing highly intelligent, automated software to accurately and efficiently clean and prepare data in a fraction of the time of traditional methods. Its software can significantly accelerate data analysis and healthcare research. AI/ML is revolutionizing the healthcare industry,” said Schiess. Built on Experience.

Life Science

Life Science Drug Development Digital Health Health Data

Self-sovereign identity (SSI) - the future of Health Data?

Lloyd Price

FEBRUARY 2, 2024

Enhanced research efficiency: Researchers can gain faster access to anonymized patient data with patient consent through SSI, accelerating research efforts and drug development. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

Health Data

Health Data Interoperability healthcare technology Leadership

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

Lloyd Price

FEBRUARY 22, 2024

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Subscribe Today!

Pain management

Pain management Mental health Telehealth healthcare technology

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Digital Health Global

NOVEMBER 20, 2023

–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. in 2060.

Life Science

Life Science Digital Health Drug Development Patient Experience

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development

Drug Development Pharmaceuticals Life Science Digital Health

AI Executive Order, the Full Breakdown

Digital Health Wire

NOVEMBER 5, 2023

However, generative AI products that respond to human queries require “a vastly different paradigm” to regulate, and FDA Digital Health Director Troy Tazbaz believes any new structure will involve ongoing audits to ensure continuous safety. The post AI Executive Order, the Full Breakdown appeared first on Digital Health Wire.

Drug Development

Drug Development Digital Health

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

MAY 6, 2020

Bardy Diagnostics is a digital health and remote patient monitoring company focused on addressing a long-standing complaint by cardiac electrophysiologists and cardiologists regarding their frequent inability to clearly distinguish the P-wave on ECG strips of existing monitors. And the list will continue to be updated over time.

Connected Health

Connected Health Telehealth Pharmaceuticals EHR

Connected Health Pulse

Drug Discovery and Early Development Outsourcing Services Industry Analysis – M&As, Partnerships and the Shift Toward an End-to-end CRDMO Model will Boost Sector Expansion – ResearchAndMarkets.com

Debiopharm and ThinkingNodeLife.ai Forge a Strategic Partnership to Propel Cancer Drug Development with AI Digital Cell Clones

Trending Sources

COVID-19 has accelerated adoption of non-contact patient monitoring technology, says Frost & Sullivan analysis

The next revolution in the pharmaceutical industry: the transformative potential of AI

Digital Healthcare Transformation: Improving Patient Experience and Outcomes

Koneksa Announces Partnership with Beacon Biosignals for Clinical Trial in Sleep and Neurologic Disorders Using EEG Biomarkers

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

How can Palantir win 'hearts and minds' to deliver the NHS England Federated Data Platform?

Where are HealthTech's soft landing M&A deals in today's market?

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Bonus Features – August 7, 2022 – Patients like digital health but have security concerns, healthcare leaders optimistic “seamless” care is coming, and more

Cornerstone AI Raises $5 Million Seed to Solve Healthcare’s Data Problem

Self-sovereign identity (SSI) - the future of Health Data?

Key trends expected to shape Pain Management and Adherence markets in 2024 and beyond

AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes

Genialis Raises $13M to Build Clinical Biomarkers that Predict Patient Response

AI Executive Order, the Full Breakdown

A guide to connected health device and remote patient monitoring vendors

Stay Connected